谷歌浏览器插件
订阅小程序
在清言上使用

Efficacy and Safety of Daratumumab, Bortezomib, and Dexamethasone (D-Vd) in Relapsed or Refractory Multiple Myeloma (RRMM) Based on Cytogenetic Risk: Updated Subgroup Analysis of CASTOR.

Katja Weisel,Andrew Spencer, Suzanne Lentzsch,Hervé Avet‐Loiseau, Tomer M. Mark,Ivan Špıčka, Alberto Bosi, Vânia TM Hungria,Michèle Cavo,Je‐Jung Lee, Ajay K. Nooka,Hang Quach,Markus Munder, Meral Beksaç,Pieter Sonneveld, David Soong,Jon Ukropec,Ming Qi, María‐Victoria Mateos

Journal of Clinical Oncology(2019)

引用 37|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要